Morten Ladekarl

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Liver Metastases

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Acta oncologica (Stockholm, Sweden)

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Morten Bentestuen, Morten Ladekarl, Aage Knudsen, Helle Damgaard Zacho
Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. BMC cancer 24 (1) (2024)
Morten Bentestuen, Morten Ladekarl, Aage Knudsen, Helle Damgaard Zacho
Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. BMC cancer 24 (1) (2024)
Morten Bentestuen, Morten Ladekarl, Aage Knudsen, Helle Damgaard Zacho
Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. BMC cancer 24 (1) (2024)
Mette Thune Mouritzen, Morten Ladekarl, Henrik Hager, Trine Block Mattesen, Julie B Lippert, Malene Støchkel Frank, Anne K Nøhr, Ida B Egendal, Andreas Carus
Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers 15 (18) (2023)
Jakob Kirkegård, Morten Ladekarl, Andrea Lund, Frank Mortensen
Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation. Annals of surgical oncology (2023)
Jakob Kirkegård, Morten Ladekarl, Ida Ravnsbæk Johannsen, Frank Mortensen
Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation. The British journal of surgery (2023)
Morten Ladekarl, Anne Krogh Nøhr, Mads Sønderkær, Simon Christian Dahl, Lone Sunde, Charles Vestereghem, Christophe Kamungu Mapendano, Charlotte Aaquist Haslund, Anja Pagh, Andreas Carus, Tamás Lörincz, Kinga Nowicka-Matus, Laurids Ø Poulsen, René Johannes Laursen, Karen Dybkær, Birgitte Klindt Poulsen, Jens Brøndum Frøkjær, Anja Høegh Brügmann, Anja Ernst, Alkwin Wanders, Martin Bøgsted, Inge Søkilde Pedersen
Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital. Acta oncologica (Stockholm, Sweden) (2023)
Siren Morken, Seppo W Langer, Anna Sundlöv, Lene Weber Vestermark, Morten Ladekarl, Geir Olav Hjortland, Johanna B Svensson, Elizaveta Mitkina Tabaksblat, Torjan Magne Haslerud, Jörg Assmus, Sönke Detlefsen, Anne Couvelard, Aurel Perren, Halfdan Sorbye
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms. British journal of cancer (2023)
Kinga Nowicka-Matus, Giedrius Salkus, Mads Sønderkær, Inge Sokilde Pedersen, Anja Ernst, Magdalena Kubik, Zsuzsanna Takacs-Szabo, Morten Ladekarl
Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab. JCO precision oncology 7 (2023)
Mette Thune Mouritzen, Karen F Junker, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders Winther Mølby Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H Hansen, Anne-Cathrine Østby, Malene S Frank, Jakob Lauritsen, Jens Benn Sørensen, Seppo Wang Langer, Gitte F Persson, Jon L Andersen, Pernille H Homann, Emilie B Kristensen, Lars B Drivsholm, Martin Bøgsted, Heidi S Christensen, Mette Pøhl, Birgitte Bjørnhart
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study. Acta oncologica (Stockholm, Sweden) 61 (4) (2022)
Mette Thune Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H Hansen, Anne-Cathrine Østby, Malene S Frank, Jakob Lauritsen, Jens Benn Sørensen, Seppo Wang Langer, Gitte F Persson, Jon L Andersen, Johanna M C Frary, Lars B Drivsholm, Charles Vestereghem, Heidi S Christensen, Birgitte Bjørnhart, Mette Pøhl
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy. Cancers 13 (19) (2021)